Literature DB >> 21709954

HBV and HCV serological markers in patients with the hepatosplenic form of mansonic schistosomiasis.

Jéfferson Luis de Almeida Silva1, Veridiana Sales Barbosa de Souza, Tatiana Aguiar Santos Vilella, Ana Lúcia C Domingues, Maria Rosângela Cunha Duarte Coêlho.   

Abstract

CONTEXT: Blood transfusion is one of the major risk factors for the transmission of the hepatitis B (HBV) and C (HCV) viruses. However, there are no reports describing the endoscopic transmission of these viruses in patients with the hepatosplenic form of schistosomiasis.
OBJECTIVE: To estimate the prevalence of serological markers of HBV and HCV in patients with the hepatosplenic form of schistosomiasis and evaluate the possible risk factors associated with these infections.
METHODS: A cross-sectional study was conducted on 230 patients with hepatosplenic form of schistosomiasis who attended a university hospital in Recife, Northeastern Brazil, from February to August 2008. The patients answered a standardized questionnaire about risk factors. Serum samples were analyzed for anti-HBc total, anti-HBs, HBsAg, and anti-HCV using enzyme-linked immunosorbent assays. Univariate analysis and multiple logistic regression were performed.
RESULTS: The prevalence was 30% for anti-HBc total and/or HBsAg and 7.4% for anti-HCV. There was a higher frequency of the serological markers in females and in patients aged .50 years. A significant association was detected between the presence of anti-HCV and the receipt of six or more blood transfusions. There was no association of history and number of digestive endoscopies with the serological markers analyzed.
CONCLUSIONS: We observed a higher prevalence of serological markers for HBV and a lower prevalence of anti-HCV. Our results indicate that females and patients of an advanced age are the most affected categories and that patients that received multiple transfusions are at a higher probability of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709954     DOI: 10.1590/s0004-28032011000200008

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  2 in total

1.  Hepatitis B and Schistosoma co-infection in a non-endemic area.

Authors:  J Á Cuenca-Gómez; J Salas-Coronas; A B Lozano-Serrano; J Vázquez-Villegas; M J Soriano-Pérez; M Estévez-Escobar; A Villarejo-Ordóñez; M T Cabezas-Fernández
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-07       Impact factor: 3.267

2.  Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.

Authors:  Paul Henriot; Mathieu Castry; Liem Binh Luong Nguyen; Yusuke Shimakawa; Kévin Jean; Laura Temime
Journal:  Aliment Pharmacol Ther       Date:  2022-06-27       Impact factor: 9.524

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.